Journal
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 82, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jddst.2023.104356
Keywords
Mesoporous silica nanoparticles; Palbociclib; Osteosarcoma; Hydroxyapatite; Glutathione
Categories
Ask authors/readers for more resources
In this study, dual responsive mesoporous silica nanoparticles (MSNs) were designed to effectively deliver PB to osteosarcoma cancer cells. PB loaded MSNs showed higher drug release in the tumor microenvironment and enhanced cytotoxicity against cancer cells. This study provides a promising method for osteosarcoma treatment using PB loaded MSNs.
Palbociclib (PB) is a selective cyclin-dependent kinase 4 and 6 inhibitor that have been approved for treatment of osteosarcoma. In this study, dual responsive mesoporous silica nanoparticles (MSNs) were designed to effectively deliver PB to osteosarcoma cancer cells. MSNs were modified with disulfide bonds and capped with hydroxy-apatite (HA) to sense the changes of glutathione and pH, respectively. The size of the prepared NPs was around 250 nm as obtained from dynamic light scattering (DLS) and transmission electron microscopy (TEM). The drug loading of the NPs was 51% and 83.6% of the drug was released in an acidic pH and glutathione-rich envi-ronment, resembling a tumor are. Higher toxicity against MG-63 cells were obtained by PB loaded MSNs compared to PB alone. Moreover, confocal microscopy displayed high internalization of the NPs into osteosar-coma cells. The PB loaded MSNs also effectively induced the apoptosis in the cells (43%) and inhibited cellular proliferation in comparison to MSNs (28.47%) and control (13.08%). PB loaded HA -capped MSNs showed higher drug release in the tumor microenvironment and enhanced cytotoxicity against cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available